TCTMD - tctmd.com
CME. There is a growing recognition of the prevalence and outcomes associated with tricuspid regurgitation, whether in isolation or with concomitant diseases. This program will focus on defining the burden of disease, outlining current guideline directed medical therapy and discussing the recent evidence for transcatheter therapies.
Injectable Semaglutide Shortage Forces Physicians to Pivot
Feb 5, 2024 · And across the Atlantic, the European Medicines Agency has also put out a notice on a shortage of injectable semaglutide—specifically the Ozempic prefilled pens at doses of 0.25, 0.5, and 1 mg—due to both burgeoning demand and manufacturing issues. The agency said the shortfall is expected to continue through this year.
TCTMD Login - tctmd.com
TCTMD Login - tctmd.com. Email Address. Password. Advertisement. Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors ...
Slides | tctmd.com
Apr 14, 2024 · SCCT 2023. Boston, MA. July 27. July 30, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
When the Time Comes to Stop Oral Anticoagulation: Options and …
Sep 28, 2021 · Published in 2019, the analysis estimates the net clinical benefit of oral anticoagulation beyond age 75 in patients with AF, showing that the benefits become marginal after age 87 for warfarin and after age 92 for apixaban (Eliquis; Bristol-Myers Squibb). It shows “that we really need personalized and individualized decision-making where if ...
FDA Approves Shockwave Intravascular Lithotripsy for Calcified ...
Feb 16, 2021 · (UPDATED) The US Food and Drug Administration has cleared the Shockwave intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary artery plaques. The device uses a balloon to deliver sonic pressure waves that can pass through soft arterial tissue to “preferentially disrupt” calcified plaque and optimize stent placement.
TCT 2023 - TCTMD.com
Oct 23, 2023 · It Isn’t Always That Easy: Challenging Access Strategies, Including Intravascular Lithotripsy. Presenter: Ethan Korngold. Presentation TCT 2023.
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
Aug 28, 2024 · The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply. Tirzepatide, when used for weight loss under the brand name Zepbound, is now more affordable thanks to a …
- tctmd.com
A live broadcast from CTO and TVT conferences. Archived versions of all live broadcasts available for 1 year after the end of each meeting. Register. $995. For more information about TCTMD and TCTMD premium memberships, please contact us. Thank you! Free registration or enhanced education options through our Prime, Gold, and Platinum memberships.
‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry
Jan 10, 2020 · With a list price of $225,000 per year, tafamidis is the most expensive cardiovascular drug on the market. Mathew Maurer, MD (Columbia University Irving Medical Center, New York, NY), who published his views along with Jerry Gurwitz, MD (University of Massachusetts Medical School, Worcester), January 8, 2020, in …